Emotional stimuli receive high processing priority in attention and memory. This processing "advantage" is generally thought to be predominantly mediated by arousal. However, recent data suggest that ratings of an image's affective "impact" may be a better predictor of recollection than arousal or valence. One interpretation of these findings is that high-impact images may draw an individual's attention, thus facilitating subsequent processing. We investigated the allocation of visual attention to negative emotional images that differed in impact but were matched for valence, arousal, and other characteristics. Participants viewed a central image flanked by 2 neutral indoor or outdoor scenes and made speeded judgments about whether the neutral scenes matched. In Experiment 1, responses were slower on high-impact relative to low-impact or neutral trials. In Experiment 2, responses on high-arousal relative to low-arousal trials did not differ significantly. These data provide evidence for differential allocation of attention to distinct sets of negative, equally arousing images, and argue against the prevailing view that heightened attention to and processing of emotional stimuli relate simply to arousal or valence.
Recent advances in science, which have aided HIV-1 vaccine development, include an improved understanding of HIV-1 envelope structure and function, expansion of the pipeline with innovative vaccine strategies, promising multi-gene and multi-clade vaccines that elicit cellular immunity, conduct of clinical trials in a global network, and development of validated techniques that enable simultaneous measurement of multiple T cell vaccine-induced immune responses in humans. A common feature of several preventive vaccine strategies now in early clinical trials is their ability in nonhuman primates to attenuate clinical disease rather than completely prevent HIV-1 infection. One vaccine concept has been tested in large-scale clinical trials, two are currently in efficacy trials, and one more is poised to enter efficacy trial in the next few years. Simultaneously, expanded efforts continue to identify new designs that induce mucosal immunity as well as broadly neutralizing antibodies.
No abstract
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.